Manulife (Manufacturers Life Insurance)’s Ventyx Biosciences VTYX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,753	Closed	-$27.3K	–	3011
2025 Q1	$27.3K	Buy	23,753 +258	+1%	+$443	﹤0.01%	2879
2024 Q4	$51.5K	Sell	23,495 -245	-1%	-$555	﹤0.01%	2934
2024 Q3	$51.8K	Sell	23,740 -609	-3%	-$1.4K	﹤0.01%	2984
2024 Q2	$56.2K	Buy	24,349 +7,096	+41%	+$29.5K	﹤0.01%	2941
2024 Q1	$94.9K	Buy	17,253 +3,479	+25%	+$15.9K	﹤0.01%	2786
2023 Q4	$34K	Sell	13,774 -62,538	-82%	-$594K	﹤0.01%	2925
2023 Q3	$2.65M	Sell	76,312 -12,528	-14%	-$433K	﹤0.01%	1352
2023 Q2	$2.91M	Buy	88,840 +20,561	+30%	+$709K	﹤0.01%	1301
2023 Q1	$2.29M	Buy	68,279 +27,199	+66%	+$1.06M	﹤0.01%	1365
2022 Q4	$1.35M	Buy	41,080 +13,120	+47%	+$389K	﹤0.01%	1500
2022 Q3	$980K	Buy	+27,960	New	+$619K	﹤0.01%	1612

Other funds holding VTYX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VTYX Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 23,753 shares — an estimated $27.3K sold.

Manulife (Manufacturers Life Insurance) first reported a position in VTYX in Q3 2022 and held it in 11 quarters. The position peaked at $2.91M in Q2 2023. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

Manulife (Manufacturers Life Insurance) reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 23,753 Ventyx Biosciences shares in Q2 2025, an estimated $27.3K.
Manulife (Manufacturers Life Insurance) first reported a position in Ventyx Biosciences in Q3 2022 and held it in 11 quarters.
Manulife (Manufacturers Life Insurance)'s Ventyx Biosciences position peaked at $2.91M in Q2 2023.
114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.